Home > Financing and Incentives > Emerging Technology & Life Sciences > Bioscience Center > Incubator at North Brunswick Tenants
  • Print
  • Send to email


Incubator at North Brunswick Tenants

API Pharma Tech LLC


API Pharma Tech LLC  is a research based technology development and drug substance, drug products manufacturing & marketing company operated by highly skilled and expert scientists and business strategists.

Abidha Research Solutions
Abidha Research Solutions (ARS) is a new start-up independent contract testing laboratory that provides advanced analytical/bioanalytical and product development services.
The company will help bio/pharmaceutical and medical device companies by providing services along the entire drug development pathway. The company will offer a comprehensive range of integrated analytical.

AcrysPharm is a specialty biopharmaceutical company currently focused on R&D services and co-development of NCEs.  AcrysPharm provides screening and development services to enable pre-clinical and clinical stage formulations for biotech and pharmaceutical clients. The company  specializes in improving the bioavailability of poorly water-soluble drugs.  

Angex Pharmaceuticals Inc.

Angex Pharmaceuticals is engaged in the discovery and development of innovative medicines to address the unmet medical needs for the improvement of human health.

Aucta Pharmaceuticals, LLC


Aucta Pharmaceuticals, LLC. (AUCTA, latin-improved, enhanced) is founded by experienced pharmaceutical research scientists from the U.S. and China, and managed by U.S. pharma industry veterans. The company is located in both China and New Jersey. Their expertise is new drug product development, product label improvement and solving difficult technical issues. They have solid fundamentals and sophisticated technology platform that can rapidly tackle technical issues and propose new product concept. The company will be in the business of novel and generic formulation product development. They work with pharma companies around the world for product co-development, sponsored research and provide value adding solutions to their partners and projects.

Bellerophon Therapeutics

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. The mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. They are currently developing three product candidates, two based on their proprietary pulsatile nitric oxide delivery device, which is referred to as INOpulse, and a third device which is referred to as bioabsorbable cardiac matrix, or BCM.

BioAegis Therapeutics Inc.

BioAegis Therapeutics Inc. is a clinical stage entity commercializing groundbreaking discoveries in inflammation and infection, directed at addressing serious diseases. The Company is pursuing a portfolio of high value indications based on repletion of plasma gelsolin, an integral and ubiquitous, natural human protein.

Bright Cloud International Corp.

With academic roots in Rutgers University, Bright Cloud is a biomedical company focused in the fields of human-machine interface, virtual rehabilitation, remote rehabilitation, and integrative therapy.  Its latest product, Bright Brainer, is a Class I FDA listed medical device that provides intensive game based motor training and cognitive exercising.  


Euprotein is a bioreagent company with a particular focus on developing recombinant proteins from mammalian cells for drug discovery applications. Euprotein also develops and implements mammalian cell based protein expression technology platforms for custom production services in support of biopharmaceutical drug development

Fidelis Pharmaceuticals

Fidelis Pharmaceuticals is a commercial stage, animal health company that provides GMP pharmaceuticals formulated specifically for laboratory animals

Genesis Imaging Services


Genesis Imaging Services specializes in the pre-clinical and clinical digital imaging of tissues and biopsies by Two Photon Microscopy and Dynamic Full-Field Optical Coherence Tomography.

Genomic Prediction Inc.


Genomic Prediction offers state-of-the-art preimplantation genetic testing services including amplification products, and testing for aneuploidy, single gene disorders and polygenic disorders.

Health Interactive Inc.

Health Interactive (HI) is a digital health company providing bioinformatics data analysis.  HI provides bioinformatics analytical services for genetic testing, pharmacogenomic analysis, inherited disorders including cancers, cancer gene mutations, and other genomic analyses.

Innovera Pharmaceuticals

Innovera Pharmaceuticals specializes in the development of unique generic and branded products possessing development barriers. Innovera’s experience in developing  challenging products including patent challenges and setting up vertically integrated pharmaceutical companies that manufacture active raw materials, finished dosage forms and sell the finished products.  Innovera Pharmaceuticals is also developing improved formulations of select approved drugs including combination drugs for therapeutic indications. 

Mito BioPharma


Mito BioPharma is a biopharmaceutical company that focuses on targeting mitochondria and cellular metabolism modulation for development of therapeutics. Mitochondria are at the center of cellular metabolism and alteration in mitochondrial function contributes significantly to many diseases such as NASH, type 2 diabetes, lipid disorders, neurodegenerative diseases, cancer, and aging in general. It has long been proposed that these diseases could be effectively treated by modulating or correcting mitochondrial function. Mito BioPharma has a proprietary, small molecule-based technology and lead compounds that embody the therapeutic strategy of “correcting” or modulating such mitochondrial functions. The company expects this technology to have major impact on developing novel drugs in these therapeutic areas. Currently, the company is prioritizing liver-based diseases such as NASH, type 2 diabetes and certain liver-based orphan drug diseases. The company is currently in the lead finding phase with the anticipation of initiating IND-enabling studies in 2017. Moreover, the R&D team is generating an extended pipeline of candidate compounds suitable for other indications such as cancer and neurodegenerative diseases in order to capture the full value of its platform technology. Mito Biopharma’s core technology has been exclusively licensed from Rutgers University.

NJ Biopharmaceuticals LLC


NJ Biopharmaceuticals LLC (NJ Bio) is a Contract Research Organization geared towards providing comprehensive chemistry and biology services to biopharmaceutical- and chemical-based technology companies. The company is located in the Commercialization Center for Innovative Technologies (CCIT), a significant biotech incubator at North Brunswick in the heart of New Jersey’s “Research Corridor” with easy access to New Jersey and New York airports.
While the company has a strong background in synthetic organic chemistry and protein based biopharmaceuticals, it is a “differentiated” service provider with a niche in several areas including expertise in antibody-drug conjugates (ADCs), bioconjugation to proteins and biomaterials, linker chemistry design for conjugations, ADC constructs, and process development for small molecules and ADCs. At NJ Bio we are developing novel Protoxins which will serve as next generation toxins for Antibody drug conjugates, expertise in multi-step customized flow chemistry synthetic routes for drug intermediates and APIs along with a unique offering to design custom flow chemistry equipment in collaboration with experts at Amar Equipment Pvt. Ltd., services to manufacture research-grade protein and antibodies, and ability to develop plate-based assays to evaluate the ability of compounds to promote or inhibit cell proliferation.

SPES Pharmaceuticals

SPES Pharmaceuticals is an innovative pharmaceutical technology company dedicated to provide medications with improved clinical benefits and patient compliance through development of innovative formulation and drug delivery technologies. 

Sunnylife Pharma Inc.


Founded by a team of former Merck scientists, Sunnylife Pharma Inc. is a research services organization providing drug discovery and development activities in the areas of medicinal chemistry, target validation, lead optimization and custom synthesis.

TheWell Bioscience


TheWell Bioscience is a biotech company focusing to develop and commercialize novel cell culture and delivery systems to empower life science research. Our goal is to bridge the in vitro and in vivo studies with simple, versatile products and services to achieve better efficiency while reducing costs. A joyful spirit is a precious gift to us.

Urigen Pharmaceuticals Inc. 


Urigen Pharmaceuticals specializes in the design and implementation of innovative products for patients with urological ailments including, specifically, the development of innovative products for amelioration of Painful Bladder Syndrome (PBS), Urethritis, Nocturia and Over Active Bladder (OAB).